Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-98,470
Closed -$1.43M 3249
2025
Q3
$1.43M Buy
+98,470
New +$1.4M 0.01% 1337
2024
Q4
Sell
-40,198
Closed -$1.25M 2500
2024
Q3
$1.25M Sell
40,198
-25,101
-38% -$625K 0.01% 1110
2024
Q2
$1.01M Buy
+65,299
New +$789K 0.01% 1009
2024
Q1
Sell
-34,589
Closed -$415K 2386
2023
Q4
$415K Sell
34,589
-13,477
-28% -$110K ﹤0.01% 1457
2023
Q3
$336K Sell
48,066
-96,084
-67% -$888K ﹤0.01% 1605
2023
Q2
$1.23M Buy
+144,150
New +$1.2M 0.01% 830
2022
Q2
Sell
-24,128
Closed -$892K 3000
2022
Q1
$892K Buy
24,128
+11,294
+88% +$440K 0.01% 1157
2021
Q4
$583K Buy
12,834
+4,200
+49% +$219K ﹤0.01% 1637
2021
Q3
$547K Sell
8,634
-40,112
-82% -$3.05M ﹤0.01% 1897
2021
Q2
$4.46M Buy
+48,746
New +$3.87M 0.04% 338
2019
Q4
Sell
-20,830
Closed -$470K 1194
2019
Q3
$470K Buy
+20,830
New +$577K 0.02% 709

Other funds holding CDNA

HRT Financial's CDNA Position: Q4 2025 in Review

HRT Financial sold out of CareDx (CDNA) in Q4 2025, closing a stake of 98,470 shares — an estimated $1.43M sold.

HRT Financial first reported a position in CDNA in Q3 2019 and held it in 11 quarters. The position peaked at $4.46M in Q2 2021. 200 funds tracked by Wall St. Rank hold CDNA as of Q4 2025.

  • HRT Financial reported no remaining CareDx position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 98,470 CareDx shares in Q4 2025, an estimated $1.43M.
  • HRT Financial first reported a position in CareDx in Q3 2019 and held it in 11 quarters.
  • HRT Financial's CareDx position peaked at $4.46M in Q2 2021.
  • 200 funds tracked by Wall St. Rank held CareDx as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.